Search
Research outputs
Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS-COV-2-A Report From the EPICOVIDEHA/EPIRESEHA Registry [2025]
Salmanton-Garcia, Jon; ...; Pantic, Nikola; ...; Merelli, Maria; ...; Urosevic, Ivana
...; Cordoba, Raul; ...; (broj, koautora 96);
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report
[2025]
Salmanton, Garcia Jon; ...; Čolović, Nataša
...; (broj koautora 100);
Platelet removal/depletion for treatment of essential thrombocythemia associated extreme thrombocytosis [2019]
Balint, Bela JClinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results [2021]
Mistry, Pramod K; ...; Petakov, Milan S; ...; (broj, koautora 18)Clinical significance of genetic aberrations in secondary acute myeloid leukemia [2012]
Milosevic, Jelena D.; Puda, Ana; Malcovati, Luca; Berg, Tiina; Hofbauer, Michael; Stukalov, Alexey; Klampfl, Thorsten; Harutyunyan, Ashot S.; Gisslinger, Heinz; Gisslinger, Bettina;
Burjanivova, Tatiana; Rumi, Elisa; Pietra, Daniela; Elena, Chiara; Vannucchi, Alessandro M.; Doubek, Michael; Dvorakova, Dana; Robesova, Blanka; Wieser, Rotraud; Koller, Elisabeth; Suvajdžić-Vuković, Nada
; Tomin, Dragica
; Tošić, Nataša
; Colinge, Jacques; Racil, Zdenek; Steurer, Michael; Pavlović, Sonja
; Cazzola, Mario; Kralovics, Robert;
Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies [2012]
Puda, Ana; Milosević, Jelena D.; Berg, Tiina; Klampfl, Thorsten; Harutyunyan, Ashot S.; Gisslinger, Bettina; Rumi, Elisa; Pietra, Daniela; Malcovati, Luca; Elena, Chiara;Upgrading the evidence for the use of ambroxol in Gaucher disease and GBA related Parkinson: Investigator initiated registry based on real life data
[2021]
Istaiti, Majdolen; ...; Rodić, Predrag Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients
[2016]
Antić, Darko Enzyme replacement therapy with taliglucerase alfa: 36‐month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase
[2016]
Pastores, Gregory M.; Shankar, Suma P.; Petakov, Milan Long‐term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment‐naïve patients with Gaucher disease
[2016]
Zimran, Ari; Durán, Gloria; Mehta, Atul; Giraldo, Pilar; Rosenbaum, Hanna; Giona, Fiorina; Amato, Dominick J.; Petakov, Milan
Cooper, Peter A.; Varughese, Sheeba; Chertkoff, Raul; Brill‐Almon, Einat;
Filters
By type
- 23